Guermazi, Ali
Roemer, Frank W.
Jarraya, Mohamed
Hayashi, Daichi http://orcid.org/0000-0002-2067-5780
Article History
Received: 5 April 2023
Revised: 21 April 2023
Accepted: 23 April 2023
First Online: 1 May 2023
Declarations
:
: AG: received consultancy fees from Pfizer, Novartis, MerckSerono, TissueGene, AstraZeneca, and Regeneron. He is a shareholder, president, and director of Musculoskeletal Imaging of Boston Imaging Core Lab., LLC.FWR: consultant to Calibr and GrĂ¼nenthal. He is a shareholder, Chief Medical Officer, Director of Research, and Director of Artificial Intelligence of Boston Imaging Core Lab., LLC.MJ: nothing to disclose.DH: received publication royalties from Wolters Kluwer.